GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
1 Reason to Buy and Hold Strategy Stock for the Next Decade
Despite its wild ups and downs, this company's share price has climbed more than tenfold in the past six years.
NVDA
1 Reason to Buy and Hold Strategy Stock for the Next Decade
Despite its wild ups and downs, this company's share price has climbed more than tenfold in the past six years.
BTCUSDT
1 Reason to Buy and Hold Strategy Stock for the Next Decade
Despite its wild ups and downs, this company's share price has climbed more than tenfold in the past six years.
NVDA
QQQ Beat the Market 46% Last Year. Here’s the Volatility You’re Really Buying
QQQ’s top holding recently crossed a $3 trillion market cap threshold—and it’s not alone in that club inside this single fund. Invesco QQQ Trust, Series 1 (NASDAQ:QQQ) tracks the Nasdaq-100 Index, which holds the 100 largest non-financial companies on the Nasdaq. That exclusion of financials means the fund is structurally tilted toward technology, communications, and ... QQQ Beat the Market 46% Last Year. Here’s the Volatility You’re Really Buying
VRTX
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $612 from $596 and keeps an Overweight rating on the shares. The firm adjusted models among its biopharma coverage for IQVIA trends as well as intra-quarter updates ahead of Q1 earnings reporting from the group.Easter Sale - 70% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Sm
SNOW
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid
Stock futures are essentially flat, reflecting a market waiting for confirmation. Markets are ending the week in a cautious holding pattern, with momentum from earlier in the week fading. Easter Sale - 70% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Oil is creeping higher again, hovering near the $100 per barrel level, as doubts grow
GILD
Gilead price target raised to $175 from $171 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Gilead (GILD) to $175 from $171 and keeps an Overweight rating on the shares. The firm adjusted models among its biopharma coverage for IQVIA trends as well as intra-quarter updates ahead of Q1 earnings reporting from the group.Easter Sale - 70% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Pic
JPM
Why Monday, April 13 Begins A Critical Week For The Stock Market Rally
Monday begins a critical week for the stock market for several reasons. Lastly, on the technical side, the stock market's powerful jump on Wednesday launched new rally. Stock market performance in the coming week may help determine the strength and status of that upturn.
GS
Why Monday, April 13 Begins A Critical Week For The Stock Market Rally
Monday begins a critical week for the stock market for several reasons. Lastly, on the technical side, the stock market's powerful jump on Wednesday launched new rally. Stock market performance in the coming week may help determine the strength and status of that upturn.
NVDA
What AI Fatigue? Anthropic's Red-Hot Growth Is Going to Supercharge These 3 AI Leaders.
Anthropic's rapidly growing revenue run rate is proof that enterprise adoption of AI services remains solid.
GOOGL
What AI Fatigue? Anthropic's Red-Hot Growth Is Going to Supercharge These 3 AI Leaders.
Anthropic's rapidly growing revenue run rate is proof that enterprise adoption of AI services remains solid.
AVGO
What AI Fatigue? Anthropic's Red-Hot Growth Is Going to Supercharge These 3 AI Leaders.
Anthropic's rapidly growing revenue run rate is proof that enterprise adoption of AI services remains solid.